Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens

An inclusive, welcoming environment for LGBTQ teenagers helps all students attending high school, a new study says.

Cisgender students (those whose gender identity matches the sex they were assigned at birth) experience an increase in their own social well-being if they attend a school that promotes openness and inclusivity toward LGBTQ te...

Childhood Obesity Undercuts The American Dream For Some, Study Says

Childhood obesity could be robbing some kids of their chance at the American Dream.

Children who are obese are far less likely to climb the economic ladder as adults, compared to kids who have a normal weight, researchers recently reported in the Journal of Population Economics.

In essence, kids’ excess weight appears ...

U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes

Americans are trapped in a ruthless social media spin cycle of viral misinformation regarding science and medicine, with many actively contributing to the problem, a new Harris Poll has found.

People have come to depend on social media for news about health and science, but the poll found they also blame these platforms for the spread of m...

'Universal Donor' Blood Supplies Dangerously Low, Study Warns

Blood banks are reporting dangerously low supplies of “universal donor” O-negative blood, a new study warns.

O-negative blood can be given to patients of any blood type, making it essential in medical emergencies where a person’s blood type is unknown, researchers said.

But O-negative supplies have dropped to critic...

TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts

TrumpRx, the president's discount program for prescription drugs, is adding three more products to its site as it continues efforts to lower drug prices.

The newly added medicines include two for type 2 diabetes, Jentadueto and Jentadueto XR, and one for chronic obstructive pulmonary disease (COPD), Striverdi Respimat. 

All thre...

New Lyme Disease Vaccine Shows Strong Results in Trial

A new vaccine meant to prevent Lyme disease may be one step closer to approval.

Drugmaker Pfizer and French vaccine company Valneva said their vaccine, called LB6V, worked more than 70% of the time in a clinical trial to prevent Lyme disease in people ages 5 and older.

The companies also said the vaccine was well tolerated, with no s...